Salahudeen, Mohammed Saji

Comparison of Anticholinergic Risk Scales and Associations with Adverse Health Outcomes in Older People

Salahudeen, M. S., Hilmer, S. N., & Nishtala, P. S. (2015) · Journal of the American Geriatrics Society

Pharmaceutical Practices and Patient OutcomesBalance, Gait, and Falls Prevention

Cited by 189

Anticholinergics: theoretical and clinical overview

Nishtala, P. S., Salahudeen, M. S., & Hilmer, S. N. (2016) · Expert Opinion on Drug Safety

Pharmaceutical Practices and Patient OutcomesCholinesterase and Neurodegenerative Diseases

Cited by 167

Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review

Salahudeen, M. S., Wright, C. M., & Peterson, G. M. (2020) · Therapeutic Advances in Drug Safety

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 72

Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature

Salahudeen, M. S., Chyou, T.-Y., & Nishtala, P. S. (2016) · PLOS ONE

Pharmaceutical Practices and Patient OutcomesIntensive Care Unit Cognitive Disorders

Cited by 53